Clinical manifestations and biological markers in the natural history of HIV-1 infection. Longitudinal study;Manifestaciones clínicas y marcadores biológicos en la historia natural de la infección por el VIH-1 en niños infectados verticalmente. Estudio longitudinal

Anales Espanoles de Pediatria

Volumn 52, Issue 2, 2000, Pages 138-147

  Resino, S ^a   Bellon J M ^a   Jimenez J L ^a   Gurbindo, D ^a   Munoz Fernandez M A ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Biological phenotype; Children; HIV 1; Lymphocytes T CD4+; Prognostic markers; Survival; Viral load HIV RNA

Indexed keywords

CD4 ANTIGEN;

ARTICLE; BRAIN DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE MARKER; FEMALE; HEART DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MALE; PHENOTYPE; PREDICTION; PROGNOSIS; REGRESSION ANALYSIS; T LYMPHOCYTE SUBPOPULATION; VERTICAL TRANSMISSION; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION; VIRUS TITRATION;

BIOLOGICAL MARKERS; DISEASE TRANSMISSION, VERTICAL; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 0034449846     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection
2. Changes in plasma HIV-1 RNA and CD4+ lymphocytes counts and the risk of progression to AIDS
3. Antiretroviral therapy for HIV infection in 1996: Recommendations of an international panel
4. British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals
5. Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection
6. Viral measurement by polymerase chain reaction-based assays in human immunodeficiency virus-infected infants
7. Age-and time-related changes in extracellular viral load in children vertically infected by human immunodeficiency virus
8. The relationship between serum HIV-1 RNA levels, CD4 lymphocyte percent, and long-term mortality risk in HIV-1 infected children
9. Viral load and disease progression in infants infected with human immunodeficiency virus tipe 1
10. HIV detection, virus load, and disease progression in perinatally infected infants
11. Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-1 infected infants and children
12. Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: Importance of viral RNA and the timing of transmission on long-term outcome
13. Evaluation of surrogate markers and clinical outcomes in two-years follow-up of eighty-six human immunodeficiency virus-infected pediatric patients
14. High viral load in children long-term non progressor vertically infected with HIV-1. Immunology characterization
15. Replicative properties of human immunodeficiency virus from patients with varying severity of HIV infection
16. Association between biological properties of human imunodeficiency virus variant and risk for AIDS mortality
17. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: Frequent detection of syncytium-inducing isolates in patients with acquired immunodeficienci syndrome (AIDS) and AIDS-related complex
18. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of AIDS obtained from studies on a panel of sequential HIV isolates
19. Biologicalal phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of the disease is associated with a shift from monocytotropic to T-cell-tropic virus population
20. Biologicalal properties of HIV isolates in primary HIV infection: Consequences for the subsequent course of infection
21. Lymphocyte subsets in healthy children during the first 5 years of life
22. Immunopathogenic mechanism in human immunodeficiency virus (HIV) infection
23. Markers for progression in HIV infection
24. CD8 lymphocyte counts and serum immunoglobulin a levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years follow-up
25. CD8+ T-lymphocytes and progresion to AIDS in HIV infected men: Some observations
26. Prognostic value of an elevated CD8 lymphocyte count in HIV infection. Results of a prospective study of 152 asymptomatic HIV-positive individuals
27. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: Staging and prognostic value
28. Penumocistis carinii pneumonia among US children with perinatally acquired HIV infection
29. Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease
30. Long term non-progressors among children with perinatal HIV- infection
31. Disease patterns and survival after acquired immunodeficiency syndrome diagnosis in human immunodeficiency virus infected children
32. Relationship of virological, immunological, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection
33. Regression models and life tables
34. Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children
35. Effect of intravenous immunoglobulin (IVIG) on CD4+ lymphocyte decline in HIV-infected children in a clinical trial of IVIG infection prophylaxis
36. CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years follow-up
37. A controlled trial of IVIG for prevention serious bacterial infections
38. HIV replication during the first weeks of life
39. Natural history of human immunodeficiency virus type 1 infection in children: Prognostic value of laboratory test on bimodal progression of the disease
40. The Pediatric AIDS Siena Workshop II. Markers and determinants of disease progression in children with HIV infection
41. Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease
42. Paediatric HIV infection
43. Clinical significance of human immunodeficiency virus type 1 phenotypes in infected children
44. Prognostic value of HIV-1 biological phenotype for rate of CD4+ count cell depletion and progression to AIDS
45. Immunological and virological markers of disease progression in HIV-1 infected children
46. Plasma viremia and virus phenotype are correlates of disease progression in vertically human immunodeficiency virus type 1-infected children
47. Epidemiology, clinical features and prognostic factors of pediatric HIV infection
48. Morbidity and mortality in European children vertically infected by HIV-1: The French prospective study and the European collaborative study
49. Advances and problems in the diagnosis of human immunodeficiency virus infection in infants
50. Survival in children perinatally acquired human immunodeficiency virus type 1 infection